1. Esophageal lesions in children with symptoms of dyspepsia
   Dmitriy Yu. Latyshev et al, 2024, Russian Pediatric Journal CrossRef
2. Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect
   Shupeng Zou et al, 2024, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy CrossRef
3. Progress on the Mechanism of Visceral Hypersensitivity in Nonerosive Reflux Disease
   Cao Xu et al, 2022, Gastroenterology Research and Practice CrossRef
4. Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
   Wentao Xu et al, 2023, Therapeutic Advances in Gastroenterology CrossRef
5. New Perspectives in Endoscopic Treatment of Gastroesophageal Reflux Disease
   Federica Calabrese et al, 2023, Diagnostics CrossRef
6. A comparison of efficacy and safety of potassium‐competitive acid blocker and proton pump inhibitor in gastric acid‐related diseases: A systematic review and meta‐analysis
   Daniel Martin Simadibrata et al, 2022, Journal of Gastroenterology and Hepatology CrossRef
7. Current Management and Treatment Paradigms of Gastroesophageal Reflux Disease following Sleeve Gastrectomy
   Muaaz Masood et al, 2024, Journal of Clinical Medicine CrossRef
8. Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
   Mun Young Cho et al, 2023, The Korean Journal of Helicobacter and Upper Gastrointestinal Research CrossRef
9. Refractory Gastroesophageal Reflux Disease: A Management Update
   Francesco Rettura et al, 2021, Frontiers in Medicine CrossRef
10. Long-term changes in serum gastrin levels during standard dose vonoprazan therapy
    Satoshi Shinozaki et al, 2022, Scandinavian Journal of Gastroenterology CrossRef
11. Diagnosis and Treatment of Refractory GERD
    Alexandra Selby et al, 2023, Current Treatment Options in Gastroenterology CrossRef
12. Phenotypes of gastroesophageal reflux disease: classification, pathogenesis and diagnostic criteria: A review
    Igor V. Maev et al, 2022, Consilium Medicum CrossRef
13. Gastroesophageal Reflux Disease in Obesity: Bariatric Surgery as Both the Cause and the Cure in the Morbidly Obese Population
    Muaaz Masood et al, 2023, Journal of Clinical Medicine CrossRef
14. Vonoprazan Versus Conventional Proton Pump Inhibitor in the Therapeutic Armamentarium of Peptic Ulcer Disease and Gastroesophageal Reflux Disease
    Radu Seicean, 2022, Peptic Ulcer Disease - What's New? CrossRef
15. Predictors and timing for the development of symptomatic gastroesophageal reflux disease after successful Helicobactor pylori eradication therapy
    Satoshi Shinozaki et al, 2022, Scandinavian Journal of Gastroenterology CrossRef